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ABSTRACT 
Diseases affecting endodermal organs like the pancreas, lung and gastrointestinal (GI) tract 
have a substantial impact on human welfare. Since many of these are congenital defects that 
arise as a result of defects during development broad efforts are focused on understanding the 
development of these organs so as to better identify risk factors, disease mechanisms and 
therapeutic targets. Studies implementing model systems, like the amphibian Xenopus, have 
contributed immensely to our understanding of signaling (e.g. Wnt, FGF, BMP, RA) pathways 
and gene regulation (e.g. hhex, ptf1a, ngn3) that underlie normal development as well as 
disease progression. Recent advances in genome engineering further enhance the capabilities 
of the Xenopus model system for pursuing biomedical research, and will undoubtedly result in a 
boom of new information underlying disease mechanisms ultimately leading to advancements in 
diagnosis and therapy. 
 
Introduction 
The pancreas and gastrointestinal (GI) tract are components of the digestive system, and 
are responsible for a number of physiological functions, including the breakdown of food for 
nutrient release, absorption of water, ions, minerals, and nutrients, glucose homeostasis, and 
hormone regulation. Dysfunction arising from cells, tissues, or systems within the digestive tract 
can result in a range of human diseases or syndromes affecting any of the physiological 
functions previously mentioned. Diseases like diabetes are of massive importance to human 
health and have a huge economic impact (estimated at $245 billion by the Centers for Disease 
Control and Prevention in 2012) resulting from the cost of therapies and lost productivity from 
patients suffering from direct and indirect consequences of impaired glucose homeostasis (heart 
disease, blindness) [1]. Many of these gastrointestinal disorders are congenital defects that 
arise as a result of aberrant development. The precise molecular mechanisms underlying the 
onset or progression of gastrointestinal disorders is of great importance for the development of 
therapies and early diagnosis, and the amphibian Xenopus offers numerous advantages for 
elucidating the molecular signals controlling how the GI tract and associated organs are 
specified during embryogenesis [2].  
 
Single cell Xenopus eggs or embryos are large (~1.2mm X. laevis, 0.75mm X. tropicalis), 
making microinjection and other mechanical manipulations relatively simple. Xenopus are non-
seasonal breeders, allowing for induction of ovulation every 3 months by injection of human 
chorionic gonadotrophin hormone into mature females. A typical brood size obtained from a 
single female may reach several thousands of eggs that can be fertilized in vitro using 
homogenized male testicle as a sperm source; in vitro fertilization is particularly advantageous 
for studies that benefit from synchronously developing embryos. Xenopus embryos develop 
rapidly providing a tractable time frame for studying early development and organogenesis. 
There are two commonly used Xenopus species in research, X. tropicalis (diploid) and X. laevis 
(tetraploid) species and sequencing of both genomes has been completed revealing large 
regions of synteny with mammals including humans [3-5]. Xenopus not only provides a 
remarkably broad experimental platform, but as an amphibian it also bridges the gap between 
costly mammalian models and the evolutionarily more distant zebrafish model [6, 7]. 
 
The GI tract and associated organs develop from the endodermal germ layer, which in 
Xenopus is derived from the vegetal hemisphere of the developing embryo. Fate map studies 
provide the necessary information to enable targeted manipulation of specific regions and 
organs in the developing endoderm [8, 9]. Xenopus embryos and tadpoles represent an 
excellent source for endoderm-derived organs, and precursor tissues for molecular analysis [10-
13]. Aided by an expansive collection of expression data (e.g. in situ hybridization, microarray, 
RNA-seq) available to the community via the Xenopus website “Xenbase” (www.xenbase.org) 
  
[14-16], and the release of genome wide stage specific transcriptomic datasets in addition to 
parallel proteomic expression data [17-20], provide substantial resources that can help shape 
hypotheses directed at understanding the mechanisms of development and disease. 
 
Foregut specification 
Many congenital malformations of the gastrointestinal tract are a direct result of abnormal 
development during embryogenesis. Deciphering the molecular mechanisms that control how 
endodermal organs are specified during early development is helpful in understanding how 
these anomalies arise, and Xenopus provides unparalleled access for embryological 
manipulations at these early stages. The foregut arises from the anterior endoderm and gives 
rise to many different organs, including the liver, pancreas, duodenum and lungs [21]. Several 
recent studies have used Xenopus to decipher the molecular mechanisms controlling how these 
organs become subdivided in the early endoderm and identified interactions between the Wnt 
and BMP pathways. Microinjections into different Xenopus blastomeres at early cleavage 
stages allows for accurate targeting of specific molecules to distinct regions of the developing 
gastrointestinal tract, and can be combined with transplantations and explants of these regions 
to ascertain the effects in different conditions [22]. 
 
Using these approaches several reports showed that Wnt signaling activity must be 
excluded from the anterior endoderm to allow for proper formation of liver and pancreas [13, 23-
25]. The Zorn lab used elegant transplantations of anterior and posterior endoderm combined 
with overexpression of key Wnt components to show that Wnt signaling must be repressed 
during the initial stages of foregut development (Fig.1a). In addition, they were able to control 
the timing of activation using hormone-inducible proteins, and this allowed them to identify a 
narrow time window when Wnt must be inhibited, from the end of gastrulation at stage 11 to 
mid-neurula stage 15 [23]. This led them to identify the hhex gene as the mediator of foregut 
specification, and through promoter analysis they identified the transcription factor Vent2 as the 
key repressor of hhex expression in the posterior endoderm [23]. In agreement with this, the 
RNA binding protein Staufen 2 was recently shown to be necessary for hhex expression in the 
anterior endoderm, and its loss led to ectopic expression of vent2 in the anterior endoderm [26]. 
Subsequent studies revealed that Wnt signaling was suppressed by the secreted Wnt 
antagonist Sfrp5 [25]. These studies led to a model where Wnt signaling regulated hindgut 
development, while suppression of Wnt promoted foregut development. 
 
However, a recent study revealed that low levels of Wnt signaling are actually required for 
foregut development [27]. In that study they were able to create multiple thresholds of Wnt 
signaling using a combination of fzd7 knockdown (to eliminate Wnt signaling) with different 
doses of the small molecule BIO, which inhibits GSK3 thereby promoting Wnt signaling. They 
found that complete elimination of Wnt signaling in the anterior endoderm by fzd7 morpholino 
inhibited foregut development, while treatment with low levels of BIO in the fzd7 morphants led 
to restoration of hhex expression [27]. More recently, BMP signaling was also found to play an 
important role in the process. By comparing the gene expression profiles of anterior endoderm 
explants, either alone or with mesoderm, BMP signaling from the mesoderm was found to be 
required at these early stages to maintain foregut progenitors [28••]. They found that Sizzled 
(Szl) was induced in the endoderm by mesodermal BMP signals and that loss of szl resulted in 
agenesis of liver, thyroid, pancreas and lung. These studies point to the importance of Wnt and 
BMP signaling for proper development of foregut organs. 
 
In parallel retinoic acid (RA) signaling has been shown to promote development of foregut 
organs. A recent study by the Chen lab identified a direct RA target gene, N-myc downstream 
regulated gene 1a (ndrg1a), as being required for proper specification of the pancreas 
  
esophagus, stomach and duodenum [24•]. They showed that ndrg1 was expressed in the dorsal 
anterior endoderm and that it acted to repress Wnt signaling. Using TALEN mediated genome 
editing they demonstrated that mutations in ndrg1 resulted in pancreas, stomach and duodenum 
hypoplasia, with no effect on the liver; a similar phenotype was found in the morpholino 
knockdown embryos as well. These results provide a link between RA signaling and Wnt 
repression in the anterior endoderm and provide mechanistic insight into how the foregut is 
patterned. 
 
Epithelial morphogenesis 
Not only is Xenopus useful for studying patterning and cell fate specification, but it provides 
a useful model to study morphogenesis of the developing gut. In the last few years several 
groups have identified key components of signaling pathways required to establish and maintain 
proper gastrointestinal epithelium [25, 28-30]. Two of these studies linked Wnt and BMP 
patterning events to tissue morphogenesis [25, 28•]. In the first study they showed that sfrp5 
was required to establish proper foregut epithelium and they were able to identify that both 
canonical and noncanonical Wnt signaling was critical for specification and morphogenesis, 
respectively. As Sfrp5 inhibits Wnt ligands it is able to interfere with both canonical and 
noncanonical Wnt pathways. Since knockdown of sfrp5 resulted in defects in both patterning 
and morphogenesis of the foregut, the Zorn lab was able to identify whether each or both defect 
was due to perturbations of the canonical or noncanonical Wnt pathway. They showed that 
epithelial integrity (and not patterning defects) was restored in sfrp5 morphants by blocking 
noncanonical Wnt signaling with mutant Dsh constructs or using a JNK inhibitor. Conversely, 
patterning defects, but not epithelial integrity, were restored in sfrp5 morphants by blocking the 
canonical Wnt pathway using Dkk1 or mutant Dsh constructs. They went on to show that Wnt11 
was the target of Sfrp5 for both pathways [25], while a more recent study showed that Wnt5 was 
a target for the noncanonical Wnt pathway [31]. 
 
A recent publication from the Nascone-Yoder lab further extended the results and showed 
that JNK activity controlled the rearrangement of endodermal cells underlying elongation of the 
gut tube in Xenopus [30•]. They found that JNK activity maintained cell-cell adhesion by 
stabilizing microtubules necessary for gut tube elongation and they confirmed that JNK was not 
required for patterning the digestive tract. Similarly, shroom3, a known regulator of epithelial 
morphogenesis in the neural tube, was identified as a key regulator of epithelial morphogenesis 
in the developing Xenopus gut [29]. In that paper they demonstrated another strength of 
Xenopus to find a Pitx1 enhancer element in the shroom3 promoter and show that both pitx1 
and shroom3 were required for epithelial cell shape changes. These results demonstrate the 
strength of using Xenopus to interrogate signaling pathways responsible for patterning and 
morphogenesis of the developing gastrointestinal tract. 
 
Pancreas development 
The pancreas is an endodermaly-derived organ that initially develops from a single dorsal bud 
and two ventral buds, which by three days post-fertilization in Xenopus embryos, fuse together 
to form a single pancreas [32]. This differs from mammals, where one of the ventral bud 
regresses before fusion at E12.5 in mice [33] and six weeks of fetal development in humans 
[34]. Developmental defects occurring at these early stages of pancreas formation can lead to 
clinically recognizable anomalies, including annular pancreas or pancreas divisum that result 
from inappropriate ventral pancreas formation and dorsal pancreas agenesis [35].  
 
Xenopus provides an excellent model in which to study development of dorsal and ventral 
pancreatic buds and identify the molecular genetic differences between them. For example, by 
producing chimeric embryos where either the dorsal or ventral pancreatic bud was labeled we 
  
demonstrated that the ventral pancreatic bud cells migrate extensively into the dorsal bud after 
fusion while dorsal pancreatic bud cells do not (Fig.1b) [11••]. By isolating individual dorsal and 
ventral pancreatic buds we compared their gene expression profiles and identified several new 
genes involved in regulating cell fate specification and proliferation in the developing pancreas 
[11, 36, 37]. We showed that the tetraspanin, tm4sf3, was localized to the ventral pancreas and 
regulates fusion of the dorsal and ventral buds [11], whereas the RNA binding protein Celf3 
controls proliferation in the developing endoderm through translational activation of key cell 
cycle genes. By producing different fusion proteins between Celf3 and Celf1 we identified the 
linker region of Celf3 as responsible for the translational enhancement activity on cyclin A2 
mRNA [36]. More recently, it was shown that the transcription factor Hhex plays a critical role in 
regulating formation of the ventral pancreatic bud, but does not influence dorsal pancreas 
formation [38]. These results demonstrate the utility of Xenopus for rapid identification and 
functional analysis of new genes involved in regulating development of the dorsal and ventral 
pancreatic buds. 
 
Xenopus is also a useful platform for investigating the temporal activity of pancreatic 
transcription factors in controlling specification of individual cell fates. A recent study revealed 
that transient expression of the pancreatic endocrine transcription factor Ngn3 (using a 
hormone-inducible version) for 1-4 hours during early neurula stages promoted development of 
beta and delta cells and not alpha cells, while similar transient expression at mid-neurula stages 
promoted development of alpha, beta and delta cells [39•]. The authors then went on to isolate 
endodermal tissue four hours after Ngn3 activation and identified many new downstream targets 
of Ngn3; using morpholinos to block translation they showed that several of these new factors 
were essential for endocrine pancreatic cell development downstream of Ngn3. Other studies in 
Xenopus have also demonstrated the sufficiency of specific pancreatic transcription factors 
(Pdx1 and Ptf1a) to promote ectopic pancreatic fates either in the early endoderm or through 
transdifferentiation of liver to pancreas [12, 40-42]. Moving forward, Xenopus provides an 
excellent platform to define the pancreatic gene regulatory network and can be used to 
interrogate these relationships in high temporal resolution. The ability to combine gain-of-
function and loss-of-function techniques in developing endoderm highlight the benefits that 
Xenopus can offer for elucidating the molecular mechanisms controlling pancreatic cell fate 
specification. 
 
Diabetes 
Xenopus has also proven useful in elucidating the function of candidate genes related to 
diabetes and establishing the significance of specific gene mutations identified in humans. 
Neonatal diabetes is a form of diabetes that affects infants in their first year of life. Mitchell-Riley 
syndrome (MRS) is a neonatal diabetes syndrome that presents with hypoplastic pancreas and 
gall bladder, and intestinal atresia [43, 44]. MRS has been linked to several distinct mutations in 
the gene encoding the transcription factor, Regulatory Factor X 6 (Rfx6)[45]; these studies 
however did not address whether these specific point mutations altered Rfx6 function. Studies in 
Xenopus were performed to establish whether these specific mutations altered Rfx6 function, 
interfering with proper pancreas development and thus could contribute to the development of 
neonatal diabetes [46••]. First, they established that knockdown of rfx6 using antisense 
morpholinos to block translation of rfx6 mRNA resulted in pancreatic and endodermal defects, 
showing that rfx6 functioned similarly in Xenopus. Next, they showed that wild type rfx6 rescued 
these specific defects thus identifying an assay to test the function of mutant rfx6 versions. Last, 
they generated three different mutant versions of rfx6 that reproduced the human mutations 
found in patients and tested their ability to rescue the rfx6 knockdown phenotype; two of these 
were single point mutations that changed one amino acid. They found that none of these 
mutants versions were able to rescue the rfx6 knockdown phenotype like the wild type rfx6. This 
  
important result provided direct evidence that these specific point mutations functionally 
impaired Rfx6 pointing to a molecular mechanism responsible for the disease and demonstrates 
how Xenopus can be used to directly establish whether specific mutations identified in patients 
is causative to the disease. 
 
Defects in the pancreatic beta cell ATP-sensitive K+ (KATP) channel (Kir6.2/SUR1) have 
been associated with both neonatal diabetes and type 2 diabetes [47, 48]. The KATP channels 
are multimeric complexes comprised of four potassium channel Kir6.2 subunits (encoded by the 
KCNJ11 gene) that form the inner channel and four sulfonylurea receptor 1 (SUR1) subunits 
(encoded by the ABCC8 gene) [47]. This hetero-octameric protein complex plays an important 
role in regulating insulin secretion. The KATP channels on the beta cell membrane are open in a 
state of low glucose; as blood glucose levels increase, glucose enters the beta cell and is 
subsequently metabolized leading to an increase in intracellular ATP. The increase in ATP 
triggers closure of the KATP channels and activation of voltage sensitive calcium channels 
leading to calcium mediated insulin secretion. Loss-of-function mutations in either subunit, 
resulting in channel closure, leads to an increase in insulin secretion and subsequent 
hyperinsulinism, while gain-of-function mutations result in a decrease in insulin secretion and 
subsequent diabetes [49]. Sulfonylurea drugs are used to treat diabetes and these drugs 
increase insulin secretion by binding to SUR1 leading to closure of the KATP channel [50]. 
 
Understanding the physiological impact specific mutations have on channel activity is a key 
area of research in diabetes, and Xenopus oocytes provide a good platform to investigate the 
function of these channel proteins in the presence or absence of single gene mutations and/or 
pharmacological treatment. The X. laevis oocyte is largely transcriptionally silent, however the 
oocyte maintains a pool of maternally transcripts which provide a source for protein translation 
[51, 52]. A single female contains thousands of oocytes that are easily isolated and can be 
cultured for several days. The large size of the oocyte lends itself well to physiological 
perturbations allowing for direct measurement of channel activity via molecular or 
electrophysiological assays under a range of conditions including mutant protein, chemical 
inhibitors, or activators [53, 54]; exogenous channel coding mRNAs can be delivered by 
microinjection and the protein products are processed and trafficked to the membrane [55]. 
 
Several recent studies used Xenopus oocytes to investigate key interactions between 
sulfonylurea drugs and different variants of KATP channel subunits. In one such study they 
identified a novel heterozygous mutation of the Kir6.2 gene (i.e. W68R) in a patient with 
remitting and relapsing neonatal diabetes. To test if the W68R could be the cause of diabetes 
observed in the patient, the authors overexpressed wildtype SUR1 and wildtype or mutant 
Kir6.2 by mRNA injection in Xenopus oocytes. Using whole cell electrophysiology methods (i.e. 
patch-clamp single channel recording) the authors determined that this W68R mutation, 
replacement of tryptophan with arginine, reduced the ATP sensitivity of the channel [56•]. They 
went on to show that the sulfonylurea compound, tolbutamide maintained canonical channel 
blocking activity, despite lowered ATP mediated inhibition on Kir6.2, suggesting that patients 
harboring the W68R mutation could benefit from sulfonylurea therapy [56]. Another report from 
the same lab examined four different Kir6.2 mutations (i.e. R210C, G334D, I296L and V59M) 
associated with neonatal diabetes [57]. They expressed different combinations of wild type and 
mutant versions in Xenopus oocytes and measured channel activity using patch-clamp single 
channel recording in excised patches. During recording, patches were treated with gliclazide, 
another sulfonylurea drug, to block channel activity. Their results indicated that the G334D 
mutation rendered Kir6.2 free of any ATP mediated inhibition, thus in the presence of 
sulfonylurea the channel remained active [57]. These results help to explain why patients with a 
G334D mutation do not respond to sulfonylurea therapy. Subsequent studies reported on the 
  
interplay between sulfonylureas and Mg-nucleotides on Kir6.2/SUR1 in Xenopus oocytes. 
Briefly they found that when sulfonylureas were bound to their target on SUR1 they reduced 
Mg-binding to SUR1 decreasing normal channel-opening activity [58]. These studies represent 
rigorous physiological investigations, aided by the utility of the Xenopus oocyte, to dissect the 
mechanistic basis for efficacy of the sulfonylurea family of anti-diabetic drugs, and sheds light 
on why certain monogenic mutations lend themselves well to sulfonylurea treatment while 
others do not. 
 
Lung and thyroid development 
In addition to its well known role as a model for early patterning events and posterior foregut 
development, Xenopus has emerged as a good model system for studying development of the 
respiratory system [59, 60]. Unique among aquatic model systems, Xenopus embryos rapidly 
develop lungs in the first few days of embryogenesis, which at the molecular and histological 
level are similar to early mouse lungs [60••]. Recent studies have revealed that the key signaling 
pathways Wnt, FGF and BMP implicated in mammalian lung development are conserved in 
Xenopus lung development [60-64]. Using small molecule inhibitors and dominant negative 
FGFR1 constructs two studies showed that FGF signaling was required for specification of lung 
tissue, but not thyroid [62, 64]. Shifley et al also showed that both MEK and PI3K pathways 
downstream of FGF are essential for lung development [64]. Using an RA antagonist, RA was 
also shown to be necessary for lung specification, but only during the early stages [61, 62]. 
Interestingly, embryos treated with RA showed ectopic lung marker expression in the 
presumptive thyroid, suggesting that RA is a key regulatory switch controlling lung versus 
thyroid development. 
 
One of the strengths of Xenopus is the ease with which epistatic relationships between 
signaling pathways can be tested by simple treatment of embryos with small molecules or 
inducible proteins at different times. Taking advantage of this, Rankin et al showed that Wnt 
acts downstream of FGF signaling to induce Nkx2.1 in presumptive lung tissue [60]. They 
activated FGF signaling using a drug inducible FGFR1 construct and analyzed whether 
constitutive FGF signaling was sufficient to induce lung development in the presence of Wnt 
knockdown. Activation of FGF signaling on its own was sufficient to induce ectopic Nkx2.1 
expression in the foregut endoderm, while it had no effect in the presence of Wnt morpholinos 
[61]. Similarly, they showed that the transcription factors Osr1 and Osr2 function downstream of 
FGF, but upstream of Wnt signaling in lung development [61]. Additionally, they found that 
Osr1/Osr2 function also played a role in repressing bmp4 expression in the lateral plate 
mesoderm, linking these three signaling pathways. They showed that Osr1/Osr2 promoted lung 
specification by repressing bmp4 expression in the lateral plate mesoderm thus promoting Wnt 
and RA signaling. Although only recently emerging as a model for lung development, Xenopus 
provides a unique platform for understanding the signaling network controlling specification of 
early lung buds. 
 
Genome editing and the future of disease research in Xenopus 
In the last three years there has been an explosion of progress in the field of disease 
modeling primarily due to the emergence of genome editing tools that allow researchers to 
generate mutations in precise regions of the genome virtually at will. Two genome editing tools 
that have received much attention as of lately, are Transcriptional Activator Like Effector 
Nucleases (TALENs) and the Conserved Repetitive Interspaced Short Palindromic Repeats 
(CRISPR)/CRISPR-associated protein 9 (Cas9) system [65]. In both systems, administration of 
the genome editing tools, usually be microinjection, result in sequence specific targeting of host 
genomic DNA. The TALEN and CRISPR system are, in most cases, engineered to have 
nuclease activity, such that appropriate targeting of the locus of interest will be cleaved by the 
  
TALEN or Cas9 proteins resulting in double stand breaks (DSB) in the genomic sequence, 
which are subsequently repaired in an error prone fashion by non-homologous end-joining often 
leading to insertion and/or deletion errors (INDELS) that result coding sequences that are 
defective (i.e. frameshift, premature stop) [66-68]. 
 
TALENs and the CRISPR/Cas9 system have been used in Xenopus to generate mutations 
with much success [69-73]. For example Lei and colleagues used TALENs targeting several loci 
including the pancreatic master regulator Ptf1a resulting in pancreatic agenesis [72]. More 
recently Guo et al. provided a comprehensive report using the CRIPSR/Cas9 system for 
targeting a number of endoderm and pancreas specific factor, including Ptf1a, Hhex, Elastase, 
and Pdx1 [69•]. These studies highlight the usefulness in combining the Xenopus experimental 
platform with genome editing tools. The next level of innovation surrounding genome editing 
with the goal of modeling human disease is in the development of an efficient method for 
homology directed repair of TALEN/CRISPR induced DSB [68]. Investigators in nearly all model 
systems are contributing to these efforts and several reports of success have circulated 
including one using Xenopus [74]. Despite these considerable successes it is not completely 
clear what the effective rate for incorporation of donor genetic material is, and the efficacy for 
insertion into the precise locus absent from off targets (i.e. random insertions). Nonetheless 
these reports show incredible promise and once methods are widely established the technique 
will undoubtedly revolutionize monogenic disease characterization and modeling. 
 
One practical challenge for disease modeling in Xenopus is the breeding and maintenance 
of mutant animals, since most Xenopus laboratories are not equipped to raise many different 
lines. The National Xenopus Resource (NXR) benefits researchers from Xenopus and non-
Xenopus laboratories by providing access to an expanding repertoire of Xenopus lines available 
for delivery or in house use [75]. The NXR facilitates disease modeling research through a 
multitude of services, including custom mutant lines and a research hotel service. In the custom 
mutant service the NXR designs, clones and injects the CRISPR and TALEN constructs and 
then grows the animals to adulthood. A research hotel service enables investigators to come to 
the Marine Biological Laboratory for short-term visits and utilize NXR infrastructure, animals and 
expertise for a wide range of Xenopus laboratory technique, including genome engineering. 
Investigators can utilize these tools to generate custom animal lines necessary for their own 
research program, while leaving the challenge of raising these animals to the NXR [75]. 
Resources like the NXR provide a center for rapid disease modeling in Xenopus, and a 
mechanism for delivering these valuable new tools to the greater research community. 
 
 
Concluding remarks 
The purpose for this review is to provide the reader with an overview of recent studies and 
advancements for understanding human pancreas and gastrointestinal disease using the 
Xenopus as a platform for discovery. The major take home message from this review is the 
diversity of research questions that can be addressed using Xenopus to address the 
mechanistic basis of disease in the developing gastrointestinal tract. Implementation of gene 
editing techniques will only enhance the utility of this model for human disease modeling. 
 
  
Figure Legend 
 
Figure 1. Two examples illustrating how transplantations are used in Xenopus. a) 
Transplantation of labeled anterior or posterior endodermal fragments expressing specific Wnt 
signaling factors (beta catenin or Gsk3b) into an unlabeled host embryos at gastrula stages 
established that Wnt signaling acted directly on the endoderm. (Reproduced with permission 
from Development [23]) b) To establish the behavior of dorsal versus ventral pancreatic bud 
cells, chimeric embryos were made between wild type and transgenic Elas-GFP Xenopus 
embryos by transplanting dorsal pieces at the tail bud stage. These experiments revealed that 
the ventral pancreatic bud cells migrate extensively after fusion, while the dorsal bud cells did 
not. (Reproduced with permission from Development [11]) 
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